首页> 外国专利> Crystalline form of bis(L-arginine)copper(II)diazide hydrate 1/3 complex and its production method

Crystalline form of bis(L-arginine)copper(II)diazide hydrate 1/3 complex and its production method

机译:双(L-精氨酸)铜(II)二叠氮化物水合物1/3配合物的晶型及其制备方法

摘要

The report concerns the crystalline form of the bis(L-arginine)diazydomide(II) hydrate 1/3, model 1, used as an antifungal and antibacterial constituent. The notification shall also cover the production of a crystalline form of bis(L-arginine)diazydomide(II) hydrate 1/3 of model 1, which is characterised by one molar part of the hydrogenated copper oxide salt (II),is dissolved in water and reacted with two molar parts of the L-arginine solution, the resulting mixture is then reacted with two molar parts of the KN3 aqueous solution and the clear mixture is left to evaporate slowly at room temperature, A crystalline form of bis(L-arginine)diazydomide(II) hydrate 1/3 with formula 1 is obtained after at least forty days.
机译:该报告涉及模型1的双(L-精氨酸)二氮杂双(II)水合物1/3的晶体形式,用作抗真菌和抗菌成分。通知还应涵盖模型1的结晶形式的双(L-精氨酸)二氮杂双(II)水合物1/3的结晶形式,其特征是将一摩尔份的氢化氧化铜盐(II)溶于将水与2摩尔份的L-精氨酸溶液反应,然后将所得混合物与2摩尔份的KN3水溶液反应,并将澄清的混合物在室温下缓慢蒸发,即双(L-至少四十天后获得具有式1的精氨酸)二氮杂双(II)水合物1/3。

著录项

  • 公开/公告号PL431213A1

    专利类型

  • 公开/公告日2020-04-06

    原文格式PDF

  • 申请/专利权人 POLITECHNIKA WROCŁAWSKA;

    申请/专利号PL20190431213

  • 发明设计人 AGNIESZKA WOJCIECHOWSKA;JAN JANCZAK;

    申请日2019-09-19

  • 分类号C07F1/08;C07C229/76;A61P31/04;A61P31/10;

  • 国家 PL

  • 入库时间 2022-08-21 11:16:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号